Efficacy of Chloroquine and Sulphadoxine‐Pyrimethamine either alone or in combination before introduction of ACT as first‐line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India
Open Access
- 12 May 2011
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 16 (8) , 929-935
Abstract
Objective In India, till recently, Chloroquine was used as first‐line therapy in areas with Chloroquine sensitive Plasmodium falciparum malaria cases. The National Vector Borne Disease Control Programme (NVBDCP) has introduced artemisinin combination therapy (ACT) as first‐line option to treat all P. falciparum cases in the country. This study was carried out to ascertain the efficacy of Chloroquine and Sulphadoxine‐Pyrimethamine, either alone or in combination, before the launch of ACT by NVBDCP. Methods A total of 300 P. falciparum malaria cases were enrolled randomly in three study arms, Chloroquine (CQ), Sulphadoxine‐Pyrimethamine (SP) and Chloroquine plus Sulphadoxine‐Pyrimethamine (CQ + SP). All patients were followed up for 28 days as per WHO (Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria, Geneva, 2003) Protocol. Paired blood samples of treatment failure cases were collected and subjected to MSP 1, MSP 2 and GLURP genotyping for differentiation between re‐infection and recrudescence. The data were analysed by Kaplan–Meier survival curve according to WHO standard procedures. Results The overall failure rate including both early treatment failure (ETF) and late treatment failure (LTF) of CQ, SP and CQ + SP were 61%, 14% and 8%, respectively, in the study area. Of 60 recurrent malaria cases, genotyping was successful in 49 cases, revealing that most of the (46/49; 94%) cases of recurrent malaria were due to recrudescence. Conclusion In Jalpaiguri District the overall failure rate of CQ was 61% and of SP 14%, which was well above the WHO recommended cut‐off threshold level (10%) for change of drug policy.Keywords
This publication has 18 references indexed in Scilit:
- Therapeutic efficacy of chloroquine and sequence variation inpfcrtgene among patients withfalciparummalaria in central IndiaTropical Medicine & International Health, 2009
- Battling the malaria iceberg with chloroquine in IndiaMalaria Journal, 2007
- Pfcrt haplotypes and in-vivo chloroquine response in Sundergarh district, Orissa, IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Open randomized study of artesunate‐amodiaquine vs. chloroquine‐pyrimethamine‐sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian childrenTropical Medicine & International Health, 2005
- Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo‐Myanmar border areasTropical Medicine & International Health, 2005
- Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective studyBMJ, 2004
- A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine–pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malariaPathogens and Global Health, 2000
- High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in TanzaniaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in ZaireTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- The development and spread of drug-resistant malariaParasitology Today, 1991